B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
Gordon J. Freeman(Dana-Farber Cancer Institute), L M Nadler(Dana-Farber Cancer Institute), Xiao-Yen Ke(Harvard University), Paul D. Rennert(Integrated BioTherapeutics (United States)), Gregory M. Bernstein(Harvard University), John G. Grlbben(Harvard University), Anukanth Anumanthan(Boston University), Gary S. Gray(Repligen (United States)), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center)
Cited by 565
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k